CA2180730A1 - Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation - Google Patents

Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation

Info

Publication number
CA2180730A1
CA2180730A1 CA002180730A CA2180730A CA2180730A1 CA 2180730 A1 CA2180730 A1 CA 2180730A1 CA 002180730 A CA002180730 A CA 002180730A CA 2180730 A CA2180730 A CA 2180730A CA 2180730 A1 CA2180730 A1 CA 2180730A1
Authority
CA
Canada
Prior art keywords
nch2oh
choh
alkyl
arylidene
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002180730A
Other languages
English (en)
Other versions
CA2180730C (fr
Inventor
Franco Buzzetti
Gabriella Maria Brasca
Antonio Longo
Dario Ballinari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2180730A1 publication Critical patent/CA2180730A1/fr
Application granted granted Critical
Publication of CA2180730C publication Critical patent/CA2180730C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
CA002180730A 1994-11-28 1995-10-30 Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation Expired - Fee Related CA2180730C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9423997A GB9423997D0 (en) 1994-11-28 1994-11-28 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
GB9423997.7 1994-11-28
PCT/EP1995/004247 WO1996016964A1 (fr) 1994-11-28 1995-10-30 Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation

Publications (2)

Publication Number Publication Date
CA2180730A1 true CA2180730A1 (fr) 1996-06-06
CA2180730C CA2180730C (fr) 2006-09-12

Family

ID=10765093

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002180730A Expired - Fee Related CA2180730C (fr) 1994-11-28 1995-10-30 Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation

Country Status (22)

Country Link
US (1) US5719135A (fr)
EP (1) EP0741726B1 (fr)
JP (1) JPH09508924A (fr)
CN (1) CN1139929A (fr)
AT (1) ATE186727T1 (fr)
AU (1) AU3926295A (fr)
CA (1) CA2180730C (fr)
DE (1) DE69513383T2 (fr)
DK (1) DK0741726T3 (fr)
ES (1) ES2140717T3 (fr)
FI (1) FI962954A0 (fr)
GB (1) GB9423997D0 (fr)
GR (1) GR3032535T3 (fr)
HU (1) HUT74875A (fr)
IL (1) IL116002A0 (fr)
MX (1) MX9602838A (fr)
NO (1) NO963066L (fr)
NZ (1) NZ295668A (fr)
PL (1) PL315689A1 (fr)
PT (1) PT741726E (fr)
WO (1) WO1996016964A1 (fr)
ZA (1) ZA959927B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6316635B1 (en) 1995-06-07 2001-11-13 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9611797D0 (en) * 1996-06-06 1996-08-07 Pharmacia Spa Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
US6316429B1 (en) 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6486185B1 (en) 1997-05-07 2002-11-26 Sugen, Inc. 3-heteroarylidene-2-indolinone protein kinase inhibitors
US6987113B2 (en) 1997-06-11 2006-01-17 Sugen, Inc. Tyrosine kinase inhibitors
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
JP2002507598A (ja) * 1998-03-26 2002-03-12 スージェン・インコーポレーテッド チロシン蛋白質キナーゼを調節するためのヘテロ環式化合物のファミリー
US6514981B1 (en) 1998-04-02 2003-02-04 Sugen, Inc. Methods of modulating tyrosine protein kinase function with indolinone compounds
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
CO5031249A1 (es) 1998-05-29 2001-04-27 Sugen Inc Pirrol substituido-2-indolinonas inhibidoras de proteinci-nasas
CN1261098C (zh) 1998-08-28 2006-06-28 西奥斯股份有限公司 p38-α激酶的抑制剂
KR20010101266A (ko) 1998-12-17 2001-11-14 프리돌린 클라우스너, 롤란드 비. 보레르 Jnk 단백질 키나제의 억제제로서의 4-아릴옥신돌
PT1157019E (pt) * 1998-12-17 2003-06-30 Hoffmann La Roche 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2
AU767138B2 (en) 1998-12-17 2003-10-30 F. Hoffmann-La Roche Ag 4,5-pyrazinoxindoles as protein kinase inhibitors
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6541477B2 (en) 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
EP1244672B1 (fr) * 1999-12-21 2005-07-20 Sugen, Inc. 7-aza-indoline-2-ones substitues en 4 et leur utilisation comme inhibiteurs de proteine kinase
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
CA2410509A1 (fr) 2000-06-02 2001-12-13 Sugen, Inc. Derives d'indolinone comme inhibiteurs de phosphatase/proteine kinase
US6335342B1 (en) 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
EP1353693B1 (fr) 2001-01-16 2005-03-16 Glaxo Group Limited Combinaison pharmaceutique contenant de l'amino-4 quinazoline et paclitaxel, carboplatin or vinorelbine pour le traitement du cancer
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
JP2005508337A (ja) * 2001-09-27 2005-03-31 スミスクライン ビーチャム コーポレーション 化合物
BRPI0707312B1 (pt) * 2006-01-27 2022-06-07 Shanghai Hengrui Pharmacetical Co., Ltd Inibidores de pirrolo [3,2-c] piridina-4-ona 2-indolinona proteína cinase, seu uso e seu processo de fabricação, intermediário e seus processos de fabricação, composição farmacêutica e seu uso
CN101367801B (zh) * 2007-08-15 2011-01-12 上海恒瑞医药有限公司 吡咯并六元n杂环羟基吗啡啉类衍生物的制备方法及其在医药上的应用
US9493452B2 (en) * 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
WO2013142831A1 (fr) 2012-03-23 2013-09-26 Southern Methodist University Procédés permettant de fabriquer et d'utiliser des dérivés de thioxothiazolidine et de rhodanine en tant qu'inhibiteurs de vih-1 et de jsp-1
CN103864784B (zh) * 2014-02-28 2017-05-03 温州医科大学 一种新型氮杂吲哚‑2‑酮类fgfr1抑制剂及其抗肿瘤活性
WO2022006238A1 (fr) * 2020-07-01 2022-01-06 Angion Biomedica Corp. Formes solides de (z)-méthyl 3-(((4-(n-méthyl-2-(4-méthylpipérazin-1-yl)acétamido)phényl)amino)(phényl)méthylène)-2-oxo-2, 3-dihydro-1h-pyrrolo[2,3-b]pyridine-6-carboxylate et des sels de celui-ci
WO2022120181A1 (fr) 2020-12-03 2022-06-09 Mydecine Innovations Group Inc. Nouvelles compositions d'analogue de psilocine et leurs procédés de synthèse
WO2024071415A1 (fr) * 2022-09-30 2024-04-04 日本ポリケム株式会社 Composé, complexe métallique, composition de catalyseur pour la polymérisation d'oléfines, catalyseur pour la polymérisation d'oléfines et procédé de production de polymère d'oléfine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation

Also Published As

Publication number Publication date
NO963066D0 (no) 1996-07-23
ES2140717T3 (es) 2000-03-01
DE69513383T2 (de) 2000-05-18
IL116002A0 (en) 1996-01-31
DK0741726T3 (da) 2000-04-17
ATE186727T1 (de) 1999-12-15
EP0741726B1 (fr) 1999-11-17
FI962954A (fi) 1996-07-24
EP0741726A1 (fr) 1996-11-13
CA2180730C (fr) 2006-09-12
AU3926295A (en) 1996-06-19
MX9602838A (es) 1997-06-28
ZA959927B (en) 1996-06-10
PL315689A1 (en) 1996-11-25
US5719135A (en) 1998-02-17
GR3032535T3 (en) 2000-05-31
HU9602357D0 (en) 1996-11-28
JPH09508924A (ja) 1997-09-09
PT741726E (pt) 2000-04-28
GB9423997D0 (en) 1995-01-11
NZ295668A (en) 1997-11-24
HUT74875A (en) 1997-02-28
CN1139929A (zh) 1997-01-08
WO1996016964A1 (fr) 1996-06-06
NO963066L (no) 1996-07-23
DE69513383D1 (de) 1999-12-23
FI962954A0 (fi) 1996-07-24

Similar Documents

Publication Publication Date Title
CA2180730A1 (fr) Composes 3-arylidene-7-azaoxindoles substitues et leur procede de preparation
MX9600686A (es) Compuestos de azaindolilideno substituidos y proceso para su preparacion.
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
ES8400730A1 (es) Un procedimiento para preparar derivados de tetralina
NZ332363A (en) substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments
ES8607298A1 (es) Procedimiento para la preparacion de pirazolopiridinas.
ES8602783A1 (es) Un procedimiento para la preparacion de pirazolopiridinas.
IE863374L (en) Indoles.
CA2273894A1 (fr) Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
CA2189534A1 (fr) Derives d'imidazole et leurs procedes de preparation
GR79244B (fr)
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
ES546646A0 (es) Un procedimiento para preparar un compuesto relacionado con arfamenina

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed